RNXT RenovoRx Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: RNXT

Price (delayed)

$0.9665

Market cap

$43.59M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.33

Enterprise value

$31.3M

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 18
Highlights
RenovoRx's debt has shrunk by 58% YoY and by 27% QoQ
RNXT's gross profit is up by 47% since the previous quarter
The company's equity has surged by 108% QoQ but it fell by 14% YoY
The quick ratio has soared by 80% from the previous quarter but it has contracted by 23% YoY
The net income has declined by 21% year-on-year and by 10% since the previous quarter
Sector: Healthcare
Industry: Biotechnology
Peers: OLMA OMER VIVS ORIC

Key stats

What are the main financial stats of RNXT

RNXT stock price

How has the RenovoRx stock price performed over time
Intraday
6.72%
1 week
-2.28%
1 month
9.18%
1 year
-30.47%
YTD
15.05%
QTD
-4.31%

Financial performance

How have RenovoRx's revenue and profit performed over time
Revenue
$1.49M
Gross profit
$1.17M
Operating income
-$12.87M
Net income
-$12.27M
Gross margin
78.7%
Net margin
-824%
The company's operating margin has surged by 82% YoY and by 22% QoQ
RenovoRx's net margin has surged by 81% YoY and by 17% QoQ
RNXT's gross profit is up by 47% since the previous quarter
The company's revenue rose by 33% QoQ

Price vs fundamentals

How does RNXT's price correlate with its fundamentals

Growth

What is RenovoRx's growth rate over time

Valuation

What is RenovoRx stock price valuation
P/E
N/A
P/B
3.87
P/S
24.69
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
21.02
The EPS has grown by 18% YoY but it has contracted by 3.1% from the previous quarter
The company's equity has surged by 108% QoQ but it fell by 14% YoY
The P/B is 97% below the 5-year quarterly average of 136.5 and 28% below the last 4 quarters average of 5.0
The P/S is 47% lower than the last 4 quarters average of 43.8
The company's revenue rose by 33% QoQ

Efficiency

How efficient is RenovoRx business performance
The ROS has soared by 81% YoY and by 17% from the previous quarter
RNXT's ROA is down by 19% YoY and by 15% from the previous quarter
RNXT's ROE is down by 16% YoY and by 16% QoQ

Dividends

What is RNXT's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for RNXT.

Financial health

How did RenovoRx financials performed over time
The quick ratio has soared by 80% from the previous quarter but it has contracted by 23% YoY
The current ratio has soared by 78% since the previous quarter but it has declined by 21% year-on-year
RenovoRx's debt is 99% lower than its equity
The company's equity has surged by 108% QoQ but it fell by 14% YoY
RenovoRx's debt has shrunk by 58% YoY and by 27% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.